This module is designed to provide the foundational knowledge for integrating the patient perspective into the full medicines lifecycle, including regulatory decision making and post-marketing efforts, which can improve patient outcomes and increase the success of the product. The concepts covered in this course apply to drugs, biologics, devices, and any medical/therapeutic products developed for patient use.

Learning objectives

Upon completion of this module, learners should be able to: Describe why integration of the patient perspective is integral for drug development programs Explain how other companies have executed and benefited from such programs Explain, from a patient point of view, what constitutes meaningful engagement List steps a company can take to build a culture of patient engagement, and what resources exist to help

Owner (organization)

PFMD

Target audience

Patients, Regulators, Pharmaceutical companies or industry , Researchers (investigators and academic researchers), Other

Types

Guidance, Training

Formats

Online e-learning

Levels

Unknown

Language

English

Accessibility

Not applicable

Certification

No

Patients involved

No

Length of training (in hrs)

1

PFMD last access

28 Nov 2020

Organizations